Financial
Revenue analytics across all investigators and studies.
8 PIs in scope
Revenue (12M)
$2567K
+8.9% YoY
Revenue Breakdown
3M$642K
6M$1284K
12M$2567K
Avg Revenue per PI
$321K
+42.9% QoQ
Active PIs
8
Contributing to revenue
Revenue Trend
Trailing period revenue comparison
Oncology
$680K
+10.5%
2 PIs
Cardiometabolic
$676K
+11.1%
2 PIs
CNS
$701K
+13.2%
2 PIs
Infectious Diseases
$510K
+1%
2 PIs
Revenue by Therapeutic Area
- Oncology (2 PIs)$680K
- Cardiometabolic (2 PIs)$676K
- CNS (2 PIs)$701K
- Infectious Diseases (2 PIs)$510K
Revenue by Trial Phase
- Phase I$456K · 18%
- Phase II$891K · 35%
- Phase III$1123K · 44%
- Phase IV$97K · 3%
PI Financial Performance & Benchmarking
| JPDr. James PattersonMD | Midwest | Immunology | $412K | +9.4% | +14.2% | $321K peer avg (+28.3%) | |
| RMDr. Robert MartinezMD PhD | Southeast | Cardiology | $378K | +7.8% | +11.1% | $321K peer avg (+17.8%) | |
| LWDr. Lisa WangPhD | West | Oncology | $356K | +5.2% | +13.2% | $321K peer avg (+10.9%) | |
| SJDr. Sarah JohnsonMD PhD | Northeast | Oncology | $324K | +4.1% | +10.5% | $321K peer avg (+0.9%) | |
| MCDr. Michael ChenMD | West | Cardiology | $298K | +3.6% | +8.4% | $321K peer avg (-7.2%) | |
| KBDr. Kevin BrownPhD | Southeast | Immunology | $289K | -2.4% | +1% | $321K peer avg (-10%) | |
| ERDr. Emily RodriguezPhD | Southeast | Neurology | $276K | -4.8% | -2.3% | $321K peer avg (-14%) | |
| AFDr. Amanda FosterMD | Mountain | Neurology | $234K | -7.1% | -5.4% | $321K peer avg (-27.1%) |
Showing 1–8 of 8 Investigators
Rows per pagePage 1 of 1